ORG
RIGL icon

Optimist Retirement Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Optimist Retirement Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,338
Closed -$443K – 122
2025
Q4 		$443K Hold
10,338
– – 0.2% 62
2025
Q3 		$293K Buy
+10,338
New +$309K 0.13% 87

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optimist Retirement Group's RIGL Position: Q1 2026 in Review

Optimist Retirement Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 10,338 shares — an estimated $443K sold.

Optimist Retirement Group first reported a position in RIGL in Q3 2025 and held it in 2 quarters. The position peaked at $443K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Optimist Retirement Group reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Optimist Retirement Group sold 10,338 Rigel Pharmaceuticals shares in Q1 2026, an estimated $443K.
  • Optimist Retirement Group first reported a position in Rigel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Optimist Retirement Group's Rigel Pharmaceuticals position peaked at $443K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Optimist Retirement Group's 13F filing for Q1 2026, filed 11 May 2026.